Healthcare Experience


Our Healthcare experience includes 812 clients, with 73 partnered brands and 759 USAN/INN names. Below is our extensive portfolio, feel free to filter by clients, brands, category or USAN/INN Names.   ||  Click Here for Consumer/B2B Experience



CLIENTS BRANDS CATEGORY
OXIGENE fosbretabulin Oncology
OXIGENE fosbretabulin disodium Oncology
OXIGENE fosbretabulin tromethamine Oncology
OWP PHARMACEUTICALS ROWEEPRA Neurology
OVATION PHARMACEUTICALS SABRIL * Neurology
OTTOBOCK AGILIUM FREESTEP Medical Device
OTSUKA PHARMACEUTICAL ABILIFY MAINTENA * Neurology
OTSUKA PHARMACEUTICAL brexpiprazole Neurology
OTSUKA PHARMACEUTICAL DELTYBA Antibiotic
OTSUKA PHARMACEUTICAL JINARC * Nephrology
OTSUKA PHARMACEUTICAL JYNARQUE * Nephrology
OTSUKA PHARMACEUTICAL MIKELUNA Ophthalmology
OTSUKA PHARMACEUTICAL ORALTAG * Medical Device
OTSUKA PHARMACEUTICAL REXULTI * Neurology
OTSUKA PHARMACEUTICAL tolvaptan Nephrology
OTICON ALTA Medical Device
OTICON NERA Medical Device
OSSUR SYMBIONIC LEG Medical Device
OSMOTICA PHARMACEUTICAL OSMOLEX ER Neurology
OSMOTICA PHARMACEUTICAL VENALTA - Product Identity
OSI PHARMACEUTICALS GALACCTIC Clinical Trial Name
OSI PHARMACEUTICALS linsitinib Oncology
OSI PHARMACEUTICALS TARCEVA * Oncology
Oscotec cevidoplenib Immunology
ORTHOSENSOR ORTHOSENSOR Corporate Identity
ORTHOSENSOR VERASENSE Medical Device
ORTHO-MCNEIL PHARMACEUTICAL DURAGESIC Pain & Inflammation
ORTHO-MCNEIL PHARMACEUTICAL PANCREAZE Gastrointestinal
ORTHO-MCNEIL PHARMACEUTICAL RAZADYNE Neurology
ORTHO-MCNEIL PHARMACEUTICAL RAZADYNE ER Neurology
ORTHO-MCNEIL PHARMACEUTICAL TOPAMAX Neurology
ORTHO DERMATOLOGICS RETIN-A MICRO PUMP Medical Device
ORION PHARMA ARAMIS (ANDROGEN RECEPTOR INHIBITING AGENT FOR METASTATIC-FREE SURVIVAL Clinical Trial Name
ORION PHARMA COMTAN * Neurology
ORION PHARMA neluxicapone Neurology
ORION PHARMA tasipimidine Animal Health
OREXO AB ZUBSOLV * Neurology
OREXIGEN THERAPEUTICS CONTRAVE * Obesity
OPTINOSE XHANCE * Respiratory
OPKO HEALTH RAYALDEE * Nephrology
OPEXA THERAPEUTICS ABILI-T Clinical Trial Name
OPEXA THERAPEUTICS imilecleucel-t Immunology
OPEXA THERAPEUTICS IMMPATH Technology Name
Onxeo etidaligide Oncology
ONO ceralifimod immunology
ONCOTHERAPYSCIENCE tabituximab Oncology
ONCOTHERAPYSCIENCE tabituximab barzuxetan Oncology
ONCOTHERAPY SCIENCE elpamotide Oncology
ONCOTHERAPY SCIENCE latromotide Oncology
ONCOTHERAPY SCIENCE pradimotide Oncology
OncoSec tavokinogene telseplasmid Oncology
ONCOPEPTIDES melphalan flufenamide Oncology
ONCOMED brontictuzumab Oncology
ONCOMED demcizumab Oncology
OncoMed etigilimab Oncology
ONCOMED ipafricept Oncology
ONCOMED navicixizumab Oncology
ONCOMED navicixizumab Oncology
ONCOMED rosmantuzumab Oncology
ONCOMED tarextumab Oncology
ONCOMED vantictumab Oncology
ONCOLOGY THERAPEUTICS NETWORK OTN - ONCOLOGY THERAPEUTICS NETWORK Corporate Identity
OLATEC dapansutrile Pain & Inflammation
OCTREOPHARM satoreotide trizoxetan Oncology
OCTAPHARMA AB FIBRYNA * Hematology
OCTAPHARMA AB NUWIQ * Hematology
OCTAPHARMA AB PANZYGA * Immunology
OCTAPHARMA AB satoreotide Oncology
OCTAPHARMA AB VIHUMA Hematology
OCTAPHARMA CUTAQUIG Immunology
OCERA THERAPEUTICS ZYSA Gastrointestinal
OBI PHARMA adagloxad simolenin Immunology
OBAGI MEDICAL CLENZIDERM M.D. Dermatology
OBAGI MEDICAL SOLUCLENZ Dermatology


* Denotes a comprehensive report of the safety regulatory research prepared by BI/DSI for submission of this name candidate to FDA, EMA, Health Canada, JMHLW, ANVISA, ROSZDRAVNADZOR, CDSCO, CFDA, KOREA MFDS, and/or other Regulatory Agencies.

Back to top